AbTx
AbTx is a biotech firm developing next-generation antibody-drug conjugates with enzymatic precision for oncology.
$1.95M Seed ·
Source: ventureburn.com
Funding history ↓Signals
Website registeredFeb 1, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $1.95M | — | ventureburn.com |
Timeline
- Website created
Founders and team
BV
Boris VUILLERMOZ Chief Technology Officer, Co foundersource: abtx-bio.comCV
Claudine VERMOT-DESROCHES Chief Scientific Officer, Co-foundersource: abtx-bio.comME
Meddy EL ALAOUI Chief Executive Officer, Co-foundersource: abtx-bio.com
Investors
AAgence Economique Regionale De Bourgogne-franche-comte
BBpifrance Digital Venture
CCalyseed
CCapital Cell
CCovalab
DDECA-BFC
DDijon métropole
GGenopole
PPMT - Microtechnology Hub
SSantenov Dijon Bourgogne
Companies like AbTx
VVelosbioSeries B+ · Aug 2026
TTubulis$360M Series B+ · Oct 2025PPhrontline Biopharma$40M Series A · Nov 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026
AAdcendo$75M Series B+ · Apr 2026PPanTargPre Seed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/abtx (get a free API key).